Medications used to treat Parkinson’s disease, specifically dopamine precursors like levodopa/carbidopa and dopamine agonists like pramipexole and ropinirole, can promote sleep when used in low doses, but high doses may cause increased nocturnal wakefulness, decreased slow-wave sleep (SWS), and decreased sleep continuity (Leeman et al., 1987; Monti et al., 1988; Cantor and Stern, 2002).

Authors

• Person: Colten HR, Altevogt BM Organization: National Academies Press
  Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI

Sources

• Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI www.ncbi.nlm.nih.gov Colten HR, Altevogt BM · National Academies Press via serper

Referenced by nodes (5)

• Parkinson's disease concept
• Slow Wave Sleep concept
• Levodopa concept
• dopamine agonists concept
• sleep continuity disturbance concept